Rexulti 2 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FXWH3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,116
Award facts
- Contract value 100% obligated
- $6,115.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,115.87 to AmerisourceBergen Drug Corp for 30 tablets of Rexulti 2 mg on February 4, 2026, with completion targeted for February 5, 2026. This is a firm fixed-price, non-set-aside contract with performance at the awardee's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Rexulti (brexpiprazole) is an atypical antipsychotic medication used in the treatment of schizophrenia and major depressive disorder. This delivery order represents a routine pharmaceutical procurement fulfilling the Department of Defense's ongoing medical supply requirements through its established relationship with AmerisourceBergen, which operates as a critical vendor in the federal medical procurement supply chain. AmerisourceBergen is owned by parent company Cencora, Inc., which holds the overarching $999,999,999.00 IDC with DLA through December 31, 2031.
Quick answers
Who was awarded contract SPE2DR26FXWH3?
SPE2DR26FXWH3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FXWH3 worth?
The government has obligated $6,116 on SPE2DR26FXWH3.
Is contract SPE2DR26FXWH3 an order under another contract?
Yes. SPE2DR26FXWH3 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXWH3 competed?
The extent of competition for SPE2DR26FXWH3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award